165 related articles for article (PubMed ID: 4037258)
1. Clustered immunotherapy with Yellow Jacket venom. Evaluation of the influence of time interval on in vivo and in vitro parameters.
Malling HJ; Djurup R; Søndergaard I; Weeke B
Allergy; 1985 Jul; 40(5):373-83. PubMed ID: 4037258
[TBL] [Abstract][Full Text] [Related]
2. Discontinuation of yellow jacket venom immunotherapy: follow-up of 75 patients by means of deliberate sting challenge.
van Halteren HK; van der Linden PW; Burgers JA; Bartelink AK
J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 1):767-70. PubMed ID: 9438484
[TBL] [Abstract][Full Text] [Related]
3. [Results of hyposensitization with bee and wasp venom].
Adolph J; Dehnert I; Fischer JF; Wenz W
Z Erkr Atmungsorgane; 1986; 166(1):119-24. PubMed ID: 3953108
[TBL] [Abstract][Full Text] [Related]
4. Assessment of prolonged venom immunotherapy in children.
Graft DF; Schuberth KC; Kagey-Sobotka A; Kwiterovich KA; Niv Y; Lichtenstein LM; Valentine MD
J Allergy Clin Immunol; 1987 Aug; 80(2):162-9. PubMed ID: 3611537
[TBL] [Abstract][Full Text] [Related]
5. Insect-sting challenge in 324 subjects with a previous anaphylactic reaction: current criteria for insect-venom hypersensitivity do not predict the occurrence and the severity of anaphylaxis.
van der Linden PW; Hack CE; Struyvenberg A; van der Zwan JK
J Allergy Clin Immunol; 1994 Aug; 94(2 Pt 1):151-9. PubMed ID: 8064067
[TBL] [Abstract][Full Text] [Related]
6. [Antibody response pattern (specific IgE and IgG) of insect sting allergic patients in immunotherapy with venom preparations].
Wüthrich B; Arrendal H; Lanner A
Schweiz Med Wochenschr; 1981 Nov; 111(46):1756-65. PubMed ID: 7313646
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of a 12-week maintenance interval in patients treated with Hymenoptera venom immunotherapy.
Kochuyt AM; Stevens EA
Clin Exp Allergy; 1994 Jan; 24(1):35-41. PubMed ID: 8156444
[TBL] [Abstract][Full Text] [Related]
8. Rush hymenoptera venom immunotherapy is efficacious and safe.
Pasaoglu G; Sin BA; Misirligil Z
J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
[TBL] [Abstract][Full Text] [Related]
9. Specific ultrarush desensitization in Hymenoptera venom-allergic patients.
Schiavino D; Nucera E; Pollastrini E; De Pasquale T; Buonomo A; Bartolozzi F; Lombardo C; Roncallo C; Patriarca G
Ann Allergy Asthma Immunol; 2004 Apr; 92(4):409-13. PubMed ID: 15104191
[TBL] [Abstract][Full Text] [Related]
10. The IgE and IgG subclass antibody response in patients allergic to yellow jacket venom undergoing different regimens of venom immunotherapy.
Djurup R; Malling HJ; Søndergaard I; Weeke B
J Allergy Clin Immunol; 1985 Jul; 76(1):46-55. PubMed ID: 4008813
[TBL] [Abstract][Full Text] [Related]
11. Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious.
Goldberg A; Confino-Cohen R
J Allergy Clin Immunol; 2001 May; 107(5):902-6. PubMed ID: 11344360
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety.
Müller U; Helbling A; Berchtold E
J Allergy Clin Immunol; 1992 Feb; 89(2):529-35. PubMed ID: 1740583
[TBL] [Abstract][Full Text] [Related]
13. Clinical correlation of the venom-specific IgG antibody level during maintenance venom immunotherapy.
Golden DB; Lawrence ID; Hamilton RH; Kagey-Sobotka A; Valentine MD; Lichtenstein LM
J Allergy Clin Immunol; 1992 Sep; 90(3 Pt 1):386-93. PubMed ID: 1527321
[TBL] [Abstract][Full Text] [Related]
14. Rush immunotherapy for wasp venom allergy seems safe and effective in patients with mastocytosis.
Verburg M; Oldhoff JM; Klemans RJ; Lahey-de Boer A; de Bruin-Weller MS; Röckmann H; Sanders C; Bruijnzeel-Koomen CA; Pasmans SG; Knulst AC
Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):192-6. PubMed ID: 26549336
[TBL] [Abstract][Full Text] [Related]
15. Effect of prolonged venom immunotherapy on serum venom-specific IgE and IgG.
Clayton WF; Reisman RE; Georgitis JW; Wypych JI; Arbesman CE
Clin Allergy; 1983 Jul; 13(4):301-7. PubMed ID: 6883662
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the allergenicity and antigenicity of yellow jacket and hornet venoms.
Reisman RE; Mueller U; Wypych J; Elliott W; Arbesman CE
J Allergy Clin Immunol; 1982 Mar; 69(3):268-74. PubMed ID: 6801104
[TBL] [Abstract][Full Text] [Related]
17. [Standardized rapid hyposensitization with purified hymenoptera venom in wasp venom allergy. Prospective study of development of tolerance and side-effect profile].
Treudler R; Tebbe B; Orfanos CE
Hautarzt; 1997 Oct; 48(10):734-9. PubMed ID: 9441166
[TBL] [Abstract][Full Text] [Related]
18. IgG and IgE antibodies after immunotherapy with bee and wasp venom.
Kemeny DM; Lessof MH; Patel S; Youlten LJ; Williams A; Lambourn E
Int Arch Allergy Appl Immunol; 1989; 88(1-2):247-9. PubMed ID: 2707888
[TBL] [Abstract][Full Text] [Related]
19. Allergy to venom from bee or wasp: the relation between clinical and immunological reactions to insect stings.
Heinig JH; Engel T; Weeke ER
Clin Allergy; 1988 Jan; 18(1):71-8. PubMed ID: 3349594
[TBL] [Abstract][Full Text] [Related]
20. [The key role of IgG4 subclass antibodies in the development of protection against allergic reactions to insect stings].
Urbanek R; Dold S
Monatsschr Kinderheilkd; 1986 Aug; 134(8):536-40. PubMed ID: 3773921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
